← Back to headlines
Novo Nordisk Cuts Ozempic, Wegovy Prices in India to Combat Generics
Novo Nordisk has once again reduced the prices of its popular drugs Ozempic and Wegovy in India, a strategic move aimed at competing with cheaper generic alternatives in the market.
31 Mar, 18:08 — 31 Mar, 18:08
Sources
Showing 1 of 1 sources
Related Stories
Revolut Secures Conditional U.S. National Bank Charter
23m ago
Ryanair Cuts Winter Flight Capacity and Warns of Fare Increases Amid High Fuel Costs
32m ago
Canada’s Trade Surplus Narrows in July Amid Falling Exports
37m ago
Snowflake Stock Soars After AI-Driven Revenue Growth Powers Blowout Quarter
49m ago